Public Policy Resources

The Family Smoking Prevention and Tobacco Control Act (TCA) requires manufacturers of all new tobacco products to submit an application to the Food and Drug Administration’s Center for Tobacco Products (CTP) for premarket review to prove that the sale of their product is “appropriate for the protection of public health” prior to going on to the market. This is one of the most important provisions of the TCA, and was intended to prevent new, harmful tobacco products from ever being sold. Unfortunately, the premarket review of all new tobacco products has never taken full effect due to lack of enforcement by the agency, the tobacco industry continuing to sell new products without CTP authorization and implementation disruptions.

The Family Smoking Prevention and Tobacco Control Act (TCA) prohibits tobacco manufacturers from using misleading descriptors about their products and requires a substantive scientific review by the Food and Drug Administration's Center for Tobacco Products prior to using any "modified risk" claim. This is one of the most important provisions of the TCA as it directly addresses the tobacco industry's deceptive marketing practices about the harm of its products.

Tobacco use remains the leading cause of preventable death in the United States. No tobacco use is safe or without risk. Commerical tobacco product use, in any form, exposes the body to a myriad of dangerous chemicals and potential health risks.

Quitting tobacco can be challenging. However, a range of FDA-approved services are available to support individuals throughout this process.

The American Cancer Society Cancer Action Network (ACS CAN) supports a comprehensive approach to tobacco control that includes significantly increasing excise taxes on all tobacco products to generate revenue, protect kids, and save lives. Significant tobacco tax increases are one of the most effective ways to prevent kids from starting to use tobacco and help adults quit.

Llamado a la acción: La Red de Acción contra el Cáncer de la Sociedad Americana contra el Cáncer (ACS CAN) insta al Congreso a respaldar un financiamiento sostenido de $310 millones USD

In a letter to Interview magazine Editor and Chief Mel Ottenberg, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong dis

In a letter to Vanity Fair Global Editorial Director Mark Guiducci, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong disappoint